Literature DB >> 14667807

Identification of genes involved in estrogenic action in the human prostate using microarray analysis.

Jasmin Bektic1, Oliver A Wrulich, Gabriele Dobler, Kurt Kofler, Florian Ueberall, Zoran Culig, Georg Bartsch, Helmut Klocker.   

Abstract

Estrogens have profound effects on the developing prostate and are suspected to contribute to the development of benign prostatic hyperplasia, but the mechanism by which this hormone elicits its regulatory function still remains largely unknown. Using complementary RNA microarrays comprising approximately 10,000 oligonucleotide gene targets we compared differences in mRNA expression of estradiol-treated and untreated prostatic stromal cells in vitro. Based on a threshold of greater than twofold change, 228, 241, and 464 of the expressed genes were found to be regulated by estradiol after 10, 24, and 48 h of treatment, respectively. The secondary analysis of one estradiol-activated transcript, namely lipopolysaccharide-binding protein, and four estradiol-repressed genes, namely ras homolog gene family member E (RhoE/Rnd3), ubiquitin thiolesterase, interleukin 6, and interleukin 8 (IL-8), by real-time quantitative PCR confirmed the results of the microarray analysis. Moreover, IL-8 and RhoE were found to be down-regulated by estradiol at the protein level as well. We identified a set of genes involved in a wide range of cellular functions that are potentially important for understanding the molecular basis of estradiol action in the prostate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14667807     DOI: 10.1016/s0888-7543(03)00184-8

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

1.  RhoE inhibits cell cycle progression and Ras-induced transformation.

Authors:  Priam Villalonga; Rosa M Guasch; Kirsi Riento; Anne J Ridley
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 2.  Pathophysiological Functions of Rnd3/RhoE.

Authors:  Wei Jie; Kelsey C Andrade; Xi Lin; Xiangsheng Yang; Xiaojing Yue; Jiang Chang
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

3.  Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.

Authors:  Rui Yang; Yu-Xia Ma; Lin-Feng Chen; Ying Zhou; Zhan-Po Yang; Yan Zhu; Xiao-Ling Du; Jian-Dang Shi; Hong-Shun Ma; Ju Zhang
Journal:  Asian J Androl       Date:  2010-05-17       Impact factor: 3.285

4.  RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway.

Authors:  Hui Zhao; Jianping Yang; Tianli Fan; Shenglei Li; Xuequn Ren
Journal:  Tumour Biol       Date:  2012-04-03

Review 5.  Estrogenic environmental chemicals and drugs: mechanisms for effects on the developing male urogenital system.

Authors:  Julia A Taylor; Catherine A Richter; Rachel L Ruhlen; Frederick S vom Saal
Journal:  J Steroid Biochem Mol Biol       Date:  2011-07-30       Impact factor: 4.292

6.  Proliferation and phenotypic changes of stromal cells in response to varying estrogen/androgen levels in castrated rats.

Authors:  Ying Zhou; Xiang-Qian Xiao; Lin-Feng Chen; Rui Yang; Jian-Dang Shi; Xiao-Ling Du; Helmut Klocker; Irwin Park; Chung Lee; Ju Zhang
Journal:  Asian J Androl       Date:  2009-06-01       Impact factor: 3.285

Review 7.  Function and regulation of Rnd proteins in cortical projection neuron migration.

Authors:  Roberta Azzarelli; François Guillemot; Emilie Pacary
Journal:  Front Neurosci       Date:  2015-02-06       Impact factor: 4.677

8.  Classification between normal and tumor tissues based on the pair-wise gene expression ratio.

Authors:  YeeLeng Yap; XueWu Zhang; M T Ling; Xianghong Wang; Y C Wong; Antoine Danchin
Journal:  BMC Cancer       Date:  2004-10-07       Impact factor: 4.430

9.  The direction of cross affects [corrected] obesity after puberty in male but not female offspring.

Authors:  Stefan Kärst; Danny Arends; Sebastian Heise; Jan Trost; Marie-Laure Yaspo; Vyacheslav Amstislavskiy; Thomas Risch; Hans Lehrach; Gudrun A Brockmann
Journal:  BMC Genomics       Date:  2015-11-06       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.